Validating the MoCA for screening 3 81 REFERENCES American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders (revised 4th ed.). Washington, DC: American Psychiatric Association. Ballard, C. K. et al. (2015) ‘Helping you to assess cognition: A practical toolkit for clinicians’, Alzheimer’s Society and Department of Health, pp. 1–42. Available at: https://www.alzheimers.org.uk/download/ downloads/id/3475/alzheimers_society_cognitive_assessment_toolkit.pdf. Baune, B. T. and Renger, L. (2014) ‘Pharmacological and non-pharmacological interventions to improve cognitive dysfunction and functional ability in clinical depression - A systematic review’, Psychiatry Research. doi: 10.1016/j.psychres.2014.05.013. Bierman, E. J. M. et al. (2005) ‘Effects of anxiety versus depression on cognition in later life’, American Journal of Geriatric Psychiatry, 13(8), pp. 686–693. doi: 10.1097/00019442-200508000-00007. Bora, E. and Pantelis, C. (2015) ‘Meta-analysis of Cognitive Impairment in First-Episode Bipolar Disorder: Comparison With First-Episode Schizophrenia and Healthy Controls’, Schizophrenia Bulletin, 41(5), pp. 1095–1104. doi: 10.1093/schbul/sbu198. Borson, S. et al. (2013) ‘Improving dementia care: The role of screening and detection of cognitive impairment’, Alzheimer’s and Dementia. Elsevier Inc., pp. 151–159. doi: 10.1016/j.jalz.2012.08.008. Bossuyt, P. M. et al. (2015) ‘STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies’, Clinical Chemistry, 61(12), pp. 1446–1452. doi: 10.1373/clinchem.2015.246280. Brunet, M. D. et al. (2013) ‘There is no evidence base for proposed dementia screening’, BMJ (Online). doi: 10.1136/bmj.e8588. Burn, A. M. et al. (2018) ‘Dementia case-finding in hospitals: A qualitative study exploring the views of healthcare professionals in English primary care and secondary care’, BMJ Open. BMJ Publishing Group, 8(3), p. e020521. doi: 10.1136/bmjopen-2017-020521. Carson, N., Leach, L. and Murphy, K. J. (2018) ‘A re-examination of Montreal Cognitive Assessment (MoCA) cutoff scores’, International Journal of Geriatric Psychiatry, 33(2), pp. 379–388. doi: 10.1002/ gps.4756. Chambers, L. W., Sivananthan, S. and Brayne, C. (2017) ‘Is Dementia Screening of Apparently Healthy Individuals Justified?’, Advances in Preventive Medicine. Hindawi Limited, 2017, pp. 1–8. doi: 10.1155/2017/9708413. De Craen, A. J. M., Heeren, T. J. and Gussekloo, J. (2003) ‘Accuracy of the 15-item geriatric depression scale (GDS-15) in a community sample of the oldest old’, International Journal of Geriatric Psychiatry. doi: 10.1002/gps.773. Dautzenberg, G. et al. (2018) ‘Severe Cognitive Impairment Associated with a High Free but Therapeutic Total Concentration of Valproic Acid Due to Hypoalbuminemia in an Older Patient with Bipolar Disorder’, Journal of Clinical Psychopharmacology. Lippincott Williams and Wilkins, pp. 265– 268. doi: 10.1097/JCP.0000000000000872. Davis, D. H. J. et al. (2013) ‘Neuropsychological tests for the diagnosis of Alzheimer’s disease dementia and other dementias: A generic protocol for cross-sectional and delayed-verification studies’, Cochrane Database of Systematic Reviews, 2013(3). doi: 10.1002/14651858.CD010460. Davis, D. H. J. et al. (2015) ‘Montreal Cognitive Assessment for the diagnosis of Alzheimer’s disease and other dementias’, Cochrane Database of Systematic Reviews. doi: 10.1002/14651858.CD010775.pub2.
RkJQdWJsaXNoZXIy MTk4NDMw